Connection

Marco Massari to Treatment Outcome

This is a "connection" page, showing publications Marco Massari has written about Treatment Outcome.
Connection Strength

0.050
  1. The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients. PLoS One. 2021; 16(5):e0251768.
    View in: PubMed
    Score: 0.008
  2. Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia. Clin Exp Rheumatol. 2021 Sep-Oct; 39(5):1141.
    View in: PubMed
    Score: 0.008
  3. High-dose glucocorticoids pulse-therapy for beta-coronaviridae pneumonia: a systematic literature review and case-series of Coronavirus disease-2019. Clin Exp Rheumatol. 2021 Sep-Oct; 39(5):1119-1125.
    View in: PubMed
    Score: 0.008
  4. Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLoS One. 2021; 16(2):e0247275.
    View in: PubMed
    Score: 0.008
  5. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2020 10 21; 18(1):405.
    View in: PubMed
    Score: 0.008
  6. TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol. Contemp Clin Trials. 2020 11; 98:106165.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.